All lobbying filings

Red+blue Strategies

Red+blue Strategies filed a Q1 report for Genedx, LLC on April 20, 2026, reporting $80,000 in lobbying income.

Lobbying for Genedx, LLC · Health Care Diagnostics

As filed: RED+BLUE STRATEGIES for GENEDX, LLC.

All filings by Red+blue Strategies · Everything Genedx, LLC has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.

Medicare/Medicaid

Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder

Bills named in this filing 2

H.R. 4709
Newborn Screening Saves Lives Reauthorization Act of 2025
H.R. 7118
Genomic Answers for Children’s Health Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.